{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:11:03Z","timestamp":1783987863821,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the University of California, San Diego Altman Clini- cal and Translational Research Institute, via the National Institute of Health National Center for Advancing Translational Sciences","award":["program grant UL1TR001442"],"award-info":[{"award-number":["program grant UL1TR001442"]}]},{"name":"the National Institute of Health National Institute on Drug Abuse","award":["DA020041"],"award-info":[{"award-number":["DA020041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07123-7","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:01:36Z","timestamp":1783987296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dose-effect analysis of 6-APB (\u201cBenzofury\u201d) on fear memory, motor behavior, and reward"],"prefix":"10.1007","author":[{"given":"Kyla M.","family":"Whitelock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin R.","family":"Van Alstyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J.","family":"Conaboy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah L.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan G.","family":"Anagnostaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"1","key":"7123_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1101\/lm.7.1.58","volume":"7","author":"SG Anagnostaras","year":"2000","unstructured":"Anagnostaras SG, Josselyn SA, Frankland PW, Silva AJ (2000) Computer-Assisted Behavioral Assessment of Pavlovian fear conditioning in mice. Learn Mem 7(1):58\u201372. https:\/\/doi.org\/10.1101\/lm.7.1.58","journal-title":"Learn Mem"},{"issue":"6","key":"7123_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s0893-133x(99)00083-4","volume":"21","author":"Stephan G. Anagnostaras","year":"1999","unstructured":"Anagnostaras, S., Maren, S., Sage, J. et al. Scopolamine and Pavlovian Fear Conditioning in Rats: Dose-Effect Analysis. Neuropsychopharmacol 21, 731\u2013744 (1999). https:\/\/doi.org\/10.1016\/s0893-133x(99)00083-4","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"7123_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1037\/0735-7044.110.6.1397","volume":"110","author":"SG Anagnostaras","year":"1996","unstructured":"Anagnostaras SG, Robinson TE (1996) Sensitization to the psychomotor stimulant effects of amphetamine: Modulation by associative learning. Behav Neurosci 110(6):1397\u20131414. https:\/\/doi.org\/10.1037\/0735-7044.110.6.1397","journal-title":"Behav Neurosci"},{"key":"7123_CR5","doi-asserted-by":"publisher","unstructured":"Anagnostaras SG, Schallert T, Robinson TE (2002) Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology. ;26(6):703\u2009\u2013\u200915. https:\/\/doi.org\/10.1016\/S0893-133X(01)00402-X.","DOI":"10.1016\/S0893-133X(01)00402-X"},{"key":"7123_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2010.00158","author":"Stephan G. Anagnostaras","year":"2010","unstructured":"Anagnostaras SG, Wood SC, Shuman T, Cai DJ, LeDuc AD, Zurn KR, Zurn JB, Sage JR and Herrera GM (2010) Automated Assessment of Pavlovian Conditioned Freezing and Shock Reactivity in Mice Using the Video Freeze System. Front. Behav. Neurosci. 4:158. https:\/\/doi.org\/10.3389\/fnbeh.2010.00158","journal-title":"Front Behav Neurosci"},{"issue":"12","key":"7123_CR6","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1007\/s00213-020-05648-z","volume":"237","author":"SD Brandt","year":"2020","unstructured":"Brandt SD, Walters HM, Partilla JS, Blough BE, Kavanagh PV, Baumann MH (2020) The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats. Psychopharmacology 237(12):3703\u20133714. https:\/\/doi.org\/10.1007\/s00213-020-05648-z","journal-title":"Psychopharmacology"},{"issue":"2","key":"7123_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1101\/lm.033613.113","volume":"21","author":"SA Carmack","year":"2014","unstructured":"Carmack SA, Howell KK, Rasaei K, Reas ET, Anagnostaras SG (2014) Animal model of Methylphenidate\u2019s long-term memory-enhancing effects. Learn Mem 21(2):82\u201389. https:\/\/doi.org\/10.1101\/lm.033613.113","journal-title":"Learn Mem"},{"key":"7123_CR8","doi-asserted-by":"publisher","unstructured":"Carmack SA, Koob GF, Anagnostaras SG (2017) Learning and memory in addiction. Learn Memory: Compr Ref 523\u2013538. https:\/\/doi.org\/10.1016\/b978-0-12-809324-5.21101-2","DOI":"10.1016\/b978-0-12-809324-5.21101-2"},{"issue":"1","key":"7123_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2009.10.049","volume":"468","author":"SA Carmack","year":"2010","unstructured":"Carmack SA, Wood SC, Anagnostaras SG (2010) Amphetamine and extinction of cued fear. Neurosci Lett 468(1):18\u201322. https:\/\/doi.org\/10.1016\/j.neulet.2009.10.049","journal-title":"Neurosci Lett"},{"issue":"3","key":"7123_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s13181-013-0306-y","volume":"9","author":"WL Chan","year":"2013","unstructured":"Chan WL, Wood DM, Hudson S, Dargan PI (2013) Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J Med Toxicol 9(3):278\u2013281. https:\/\/doi.org\/10.1007\/s13181-013-0306-y","journal-title":"J Med Toxicol"},{"key":"7123_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuropharm.2005.03.002","volume":"49","author":"KJ Clemens","year":"2005","unstructured":"Clemens KJ, Cornish JL, Li KM, Hunt GE, McGregor IS (2005) MDMA (\u2018Ecstasy\u2019) and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacol 49:195\u2013207. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.03.002","journal-title":"Neuropharmacol"},{"key":"7123_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pnpbp.2013.08.013","volume":"48","author":"P Dawson","year":"2014","unstructured":"Dawson P, Opacka-Juffry J, Moffatt JD, Daniju Y, Dutta N, Ramsey J, Davidson C (2014) The effects of Benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat. Prog Neuropsychopharmacol Biol Psychiatry 48:57\u201363. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.08.013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"20","key":"7123_CR13","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.1523\/jneurosci.18-20-08505.1998","volume":"18","author":"TM DeLorey","year":"1998","unstructured":"DeLorey TM, Handforth A, Anagnostaras SG, Homanics GE, Minassian BA, Asatourian A, Fanselow MS, Delgado-Escueta A, Ellison GD, Olsen RW (1998a) Mice lacking the \u03b23subunit of the GABAareceptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 18(20):8505\u20138514. https:\/\/doi.org\/10.1523\/jneurosci.18-20-08505.1998","journal-title":"J Neurosci"},{"key":"7123_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang A-G (2009) Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 41:1149\u20131160","journal-title":"Behav Res Methods"},{"key":"7123_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175\u2013191","journal-title":"Behav Res Methods"},{"key":"7123_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00213-002-1320-y","volume":"166","author":"Y Itzhak","year":"2003","unstructured":"Itzhak Y, Ali SF, Achat CN, Anderson KL (2003) Relevance of MDMA (ecstasy)-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacol 166:241\u2013248. https:\/\/doi.org\/10.1007\/s00213-002-1320-y","journal-title":"Psychopharmacol"},{"issue":"1\u20133","key":"7123_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","volume":"700","author":"L Iversen","year":"2013","unstructured":"Iversen L, Gibbons S, Treble R, Setola V, Huang X-P, Roth BL (2013) Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol 700(1\u20133):147\u2013151. https:\/\/doi.org\/10.1016\/j.ejphar.2012.12.006","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"7123_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1037\/h0047726","volume":"48","author":"GA Kimble","year":"1955","unstructured":"Kimble GA (1955) Shock intensity and avoidance learning. J Comp Physiological Psychol 48(4):281\u2013284. https:\/\/doi.org\/10.1037\/h0047726","journal-title":"J Comp Physiological Psychol"},{"issue":"1","key":"7123_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1037\/0735-7044.105.1.126","volume":"105","author":"Jeansok J. Kim","year":"1991","unstructured":"Kim, J. J., DeCola, J. P., Landeira-Fernandez, J., & Fanselow, M. S. (1991). N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behavioral Neuroscience, 105(1), 126\u2013133. https:\/\/doi.org\/10.1037\/0735-7044.105.1.126","journal-title":"Behavioral Neuroscience"},{"issue":"3","key":"7123_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pbb.2009.09.020","volume":"94","author":"CE Kovacsics","year":"2010","unstructured":"Kovacsics CE, Gould TD (2010) Shock-induced aggression in mice is modified by lithium. Pharmacol Biochem Behav 94(3):380\u2013386. https:\/\/doi.org\/10.1016\/j.pbb.2009.09.020","journal-title":"Pharmacol Biochem Behav"},{"issue":"6710","key":"7123_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1126\/science.ads4470","volume":"385","author":"K Kupferschmidt","year":"2024","unstructured":"Kupferschmidt K (2024b) What\u2019s next for psychedelics after MDMA rejection? Science 385(6710):702\u2013703. https:\/\/doi.org\/10.1126\/science.ads4470","journal-title":"Science"},{"key":"7123_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.drugalcdep.2015.04.020","volume":"152","author":"A Ledberg","year":"2015","unstructured":"Ledberg A (2015) The interest in eight new psychoactive substances before and after scheduling. Drug Alcohol Depend 152:73\u201378. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.04.020","journal-title":"Drug Alcohol Depend"},{"key":"7123_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1124\/jpet.122.538870del","volume":"385","author":"C Lee","year":"2023","unstructured":"Lee C, Alstyne KR, Anagnostaras SG (2023) Effect of methylphenidate on Motor Skill Learning and consolidation. J Pharmacol Exp Ther 385:403. https:\/\/doi.org\/10.1124\/jpet.122.538870del","journal-title":"J Pharmacol Exp Ther"},{"key":"7123_CR23","doi-asserted-by":"publisher","unstructured":"Loeser JD (2000) Pain and suffering. Clin J Pain. ;16(2 Suppl):S2-6. https:\/\/doi.org\/10.1097\/00002508-200006001-00002.","DOI":"10.1097\/00002508-200006001-00002"},{"issue":"23","key":"7123_CR24","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1021\/jm00075a027","volume":"36","author":"AP Monte","year":"1993","unstructured":"Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (1993) Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogs of 3,4-(methylenedioxy)amphetamine. J Med Chem 36(23):3700\u20133706. https:\/\/doi.org\/10.1021\/jm00075a027","journal-title":"J Med Chem"},{"issue":"4","key":"7123_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1017\/S1461145712000582","volume":"16","author":"M Mueller","year":"2013","unstructured":"Mueller M, Yuan J, McCann UD, Hatzidimitriou G, Ricaurte GA (2013) Single oral doses of (\u00b1) 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations. Int J Neuropsychopharmacol 16(4):791\u2013801. https:\/\/doi.org\/10.1017\/S1461145712000582","journal-title":"Int J Neuropsychopharmacol"},{"key":"7123_CR26","doi-asserted-by":"crossref","unstructured":"Pantoni MM, Anagnostaras SG (2019) Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose. Pharmacol Rev. ;71(3):413\u2013449. https:\/\/doi.org\/10.1124\/pr.118.017087. Erratum in: Pharmacol Rev. 2021;73(2):729. https:\/\/doi.org\/10.1124\/pr.118.017087.","DOI":"10.1124\/pr.118.017087"},{"issue":"3","key":"7123_CR27","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00213-022-06086-9","volume":"239","author":"MM Pantoni","year":"2022","unstructured":"Pantoni MM, Kim JL, Van Alstyne KR, Anagnostaras SG (2022) MDMA and memory, addiction, and depression: dose-effect analysis. Psychopharmacology (Berl) 239(3):935\u2013949. https:\/\/doi.org\/10.1007\/s00213-022-06086-9","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"7123_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","volume":"25","author":"A Rickli","year":"2015","unstructured":"Rickli A, Hoener MC, Liechti ME (2015) Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones. Eur Neuropsychopharmacol 25(3):365\u2013376. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.12.012","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"7123_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","volume":"18","author":"TE Robinson","year":"1993","unstructured":"Robinson TE, Berridge KC (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18(3):247\u2013291","journal-title":"Brain Res Rev"},{"issue":"6","key":"7123_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/jcp.0000000000000962","volume":"38","author":"S Schenk","year":"2018","unstructured":"Schenk S, Newcombe D (2018) Methylenedioxymethamphetamine (MDMA) in psychiatry. J Clin Psychopharmacol 38(6):632\u2013638. https:\/\/doi.org\/10.1097\/jcp.0000000000000962","journal-title":"J Clin Psychopharmacol"},{"key":"7123_CR31","doi-asserted-by":"publisher","unstructured":"Simmler LD, Liechti ME (2018) Pharmacology of MDMA- and amphetamine-like new psychoactive substances. New Psychoact Substances 143\u2013164. https:\/\/doi.org\/10.1007\/164_2018_113","DOI":"10.1007\/164_2018_113"},{"key":"7123_CR41","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/acer.15039","volume":"47","author":"Elizabeth A. Sneddon","year":"2023","unstructured":"Sneddon, E.A., Fennell, K.A., Bhati, S., Setters, J.E., Schuh, K.M., DeMedio, J.N. et al. (2023) Greater resistance to footshock punishment in female C57BL\/6J mice responding for ethanol. Alcohol: Clinical and Experimental Research, 47, 678\u2013686. Available from: https:\/\/doi.org\/10.1111\/acer.15039","journal-title":"Alcohol: Clinical and Experimental Research"},{"key":"7123_CR32","unstructured":"The 2024 Florida Statutes: DRUG ABUSE PREVENTION AND CONTROL. Statutes & constitution: Online sunshine (2025).\u00a0http:\/\/www.leg.state.fl.us\/statutes\/index.cfm?App_mode=Display_Statute&URL=0800-0899%2F0893%2F0893.html"},{"key":"7123_CR33","unstructured":"Ugliengo P (2006) MOLDRAW: A Program to Display and Manipulate Molecular and Crystal Structures, Torino available on the web at: http:\/\/www.moldraw.unito.it"},{"issue":"1\u20132","key":"7123_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1524\/zkri.1993.207.12.9","volume":"207","author":"P Ugliengo","year":"1993","unstructured":"Ugliengo P, Viterbo D, Chiari G (1993) MOLDRAW: molecular graphics on a personal computer. Z Kristallogr - Cryst Mater 207(1\u20132):9\u201324. https:\/\/doi.org\/10.1524\/zkri.1993.207.12.9","journal-title":"Z Kristallogr - Cryst Mater"},{"issue":"12","key":"7123_CR35","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1007\/s00216-015-8552-2","volume":"407","author":"J Welter","year":"2015","unstructured":"Welter J, Brandt SD, Kavanagh P, Meyer MR, Maurer HH (2015) Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MSN techniques. Anal Bioanal Chem 407(12):3457\u20133470. https:\/\/doi.org\/10.1007\/s00216-015-8552-2","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"7123_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neulet.2011.10.006","volume":"505","author":"SC Wood","year":"2011","unstructured":"Wood SC, Anagnostaras SG (2011) Interdependence of measures in pavlovian conditioned freezing. Neurosci Lett 505(2):134\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2011.10.006","journal-title":"Neurosci Lett"},{"issue":"1\u20133","key":"7123_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00213-008-1185-9","volume":"202","author":"SC Wood","year":"2009","unstructured":"Wood SC, Anagnostaras SG (2009) Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL\/6 mice. Psychopharmacology (Berl) 202(1\u20133):197\u2013206. https:\/\/doi.org\/10.1007\/s00213-008-1185-9","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"7123_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbr.2006.10.008","volume":"176","author":"SC Wood","year":"2007","unstructured":"Wood SC, Fay J, Sage JR, Anagnostaras SG (2007) Cocaine and pavlovian fear conditioning: dose-effect analysis. Behav Brain Res 176(2):244\u201350. https:\/\/doi.org\/10.1016\/j.bbr.2006.10.008","journal-title":"Behav Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07123-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:01:38Z","timestamp":1783987298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07123-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":40,"alternative-id":["7123"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07123-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}